NDC 23155-823

Cabergoline

Cabergoline

Cabergoline is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Heritage Pharmaceuticals Inc. D/b/a Avet Pharmaceuticals Inc.. The primary component is Cabergoline.

Product ID23155-823_d3e8a769-cb6d-469c-9bf7-3fe577028668
NDC23155-823
Product TypeHuman Prescription Drug
Proprietary NameCabergoline
Generic NameCabergoline
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2022-06-15
Marketing CategoryANDA /
Application NumberANDA076310
Labeler NameHeritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
Substance NameCABERGOLINE
Active Ingredient Strength1 mg/1
Pharm ClassesErgolines [CS], Ergot Derivative [EPC]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 23155-823-73

8 TABLET in 1 BOTTLE (23155-823-73)
Marketing Start Date2022-06-15
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Cabergoline" or generic name "Cabergoline"

NDCBrand NameGeneric Name
0093-5420CabergolineCabergoline
23155-823CabergolineCabergoline
49884-673CabergolineCabergoline
50090-3157CabergolineCabergoline
50090-3951CabergolineCabergoline
50090-5834CabergolineCabergoline
50742-118CabergolineCabergoline
59762-1005Cabergolinecabergoline
68071-4596CabergolineCabergoline
70518-2379CabergolineCabergoline

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.